rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2006-2-24
|
pubmed:abstractText |
Fabry disease is a rare X-linked disorder caused by deficient activity of the enzyme alpha-galactosidase A. This produces progressive lysosomal accumulation of globotriaosylceramide throughout the body, leading to organ failure and premature death.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0803-5253
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
95
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
86-92
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16498740-Adolescent,
pubmed-meshheading:16498740-Age of Onset,
pubmed-meshheading:16498740-Child,
pubmed-meshheading:16498740-Child, Preschool,
pubmed-meshheading:16498740-DNA Mutational Analysis,
pubmed-meshheading:16498740-Fabry Disease,
pubmed-meshheading:16498740-Female,
pubmed-meshheading:16498740-Heterozygote,
pubmed-meshheading:16498740-Humans,
pubmed-meshheading:16498740-Isoenzymes,
pubmed-meshheading:16498740-Male,
pubmed-meshheading:16498740-Outcome Assessment (Health Care),
pubmed-meshheading:16498740-alpha-Galactosidase
|
pubmed:year |
2006
|
pubmed:articleTitle |
Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey.
|
pubmed:affiliation |
Department of Paediatric Endocrinology, Diabetes and Metabolism, Addenbrooke's Hospital, Cambridge, UK. uma.ramaswami@addenbrookes.nhs.uk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|